Henry A. Nasrallah, MD

University of Cincinnati Neuroscience Institute, Cincinnati, Ohio

  • 24Articles
  • 62.1KReads
  • 2002–2025Active
  • 46Collaborators
  • 186Citations

About

Henry A. Nasrallah, MD, is affiliated with the University of Cincinnati Neuroscience Institute in Cincinnati, Ohio. He has contributed 24 articles to Psychiatrist.com between 2002 and 2025, focusing on topics such as schizophrenia, schizoaffective disorders, neurology, bipolar disorder, dementia, psychiatry, and psychotic disorders. Frequent co-authors include John M. Kane, Rajiv Tandon, Anjana Bose, Bernard L. Silverman, and Elliot W. Ehrich.

Publications

JCP
Psychosocial Interventions and Functional Recovery in Schizophrenia
Academic Highlights

Psychosocial Interventions and Functional Recovery in Schizophrenia

December 17, 2025

A consensus panel of experts reviewed the evidence base for use of psychosocial interventions in schizophrenia and provides practical recommendations for optimizing functional recovery.
, , , et al
JCP
It Takes Guts to Be Mentally Ill, Part 1: A Brief Overview of the Human Gut Microbiota
Insights

It Takes Guts to Be Mentally Ill, Part 1: A Brief Overview of the Human Gut Microbiota

September 8, 2025

Dr. Henry Nasrallah introduces the human gut microbiota and its role in brain health, highlighting how early life, diet, antibiotics, and lifestyle impact microbial balance — and how gut...
JCP
It Takes Guts to Be Mentally Ill, Part 2: The Relationship Between the Gut Microbiota and Psychosis
Insights

It Takes Guts to Be Mentally Ill, Part 2: The Relationship Between the Gut Microbiota and Psychosis

September 8, 2025

Dr. Henry Nasrallah examines how gut microbiota imbalances—aka "leaky gut"—are linked to psychiatric conditions like depression, anxiety, and psychosis, and explores how diet, probiotics, and microbiome therapies may improve...
JCP
Psychosis, Inflammatory Biomarkers, and Subtypes of Childhood Trauma
Commentary

Psychosis, Inflammatory Biomarkers, and Subtypes of Childhood Trauma

May 22, 2024

Dr Nasrallah discusses a recent study by Cuñat et al of the relationship between childhood trauma and inflammation, and why this work is unique and important.
JCP
Original Research

Metabolic Effects of Aripiprazole Lauroxil

November 23, 2016

Aripiprazole lauroxil, a long-acting injectable antipsychotic, demonstrated safety and efficacy in treating schizophrenia symptoms in a recent RCT. But how does it stack up against other antipsychotics in terms...
, , , et al
JCP
Educational Activity

Consequences of Misdiagnosis: Inaccurate Treatment and Poor Patient Outcomes in Bipolar Disorder

October 21, 2015

JCP
Book Review

Treatment-Refractory Schizophrenia: A Clinical Conundrum

September 23, 2015

JCP
Original Research

A Randomized, Double-Blind, Placebo-Controlled Trial of Aripiprazole Lauroxil in Acute Exacerbation of Schizophrenia

August 26, 2015

, , , et al
JCP
Educational Activity

Setting the Stage for Success or Failure: Making an Accurate Diagnosis of Bipolar Depression

June 24, 2015

JCP
Book Review

Management of Treatment-Resistant Major Psychiatric Disorders

October 15, 2013

JCP
Book Review

Antipsychotics and Mood Stabilizers: Stahl's Essential Psychopharmacology, 3rd ed

June 18, 2009

JCP
Article

Proceedings and Data From The Schizophrenia Summit: A Critical Appraisal to Improve the Management of Schizophrenia

March 4, 2009

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe